Breast Cancer Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 years or older.
- People who have been clinically diagnosed with Cancer of Unknown Primary (CUP) syndrome — a cancer that has been found in the body but where doctors have not yet identified where it originally started.
- People where doctors suspect, based on physical examination or scans, that the cancer may have started in the breast.
- People who are able to give their informed consent to take part in the study.
- Female or transgender people who have breast tissue and are suitable for a special type of breast imaging called Contrast-Enhanced Mammography (CEM).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People where a primary (original) tumour has already been confirmed in an organ other than the breast.
- People who cannot receive iodinated contrast agents — a type of dye used in medical imaging — due to serious allergic reactions or other medical reasons.
- People with severely reduced kidney function (confirm with trial site) who cannot safely receive contrast agents.
- People who are pregnant or breastfeeding, as the contrast dye used in imaging may be harmful to an unborn baby or newborn.
- People with serious medical conditions that could affect their safety or ability to take part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Detection Rate of Primary Tumors using Contrast-Enhanced Mammography (CEM) in Patients with CUP Syndrome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.